Innovation Pharmaceuticals Inc. Quarterly Amortization of Intangible Assets in USD from Q4 2012 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Innovation Pharmaceuticals Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q4 2012 to Q3 2023.
  • Innovation Pharmaceuticals Inc. Amortization of Intangible Assets for the quarter ending September 30, 2023 was $94K, a 1.08% increase year-over-year.
  • Innovation Pharmaceuticals Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2023 was $374K, a 1.58% decline year-over-year.
  • Innovation Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2023 was $373K, a 2.36% decline from 2022.
  • Innovation Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2022 was $382K, a 1.06% increase from 2021.
  • Innovation Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2021 was $378K, a 1.61% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $374K $94K +$1K +1.08% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $373K $92K -$4K -4.17% Apr 1, 2023 Jun 30, 2023 10-K 2023-09-28
Q1 2023 $377K $94K -$1K -1.05% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $378K $94K -$2K -2.08% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-15
Q3 2022 $380K $93K -$2K -2.11% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $382K $96K +$2K +2.13% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 $380K $95K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $380K $96K +$2K +2.13% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-15
Q3 2021 $378K $95K +$1K +1.06% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $94K +$1K +1.08% Jun 1, 2021 Jun 30, 2021 10-Q 2021-05-13
Q1 2021 $376K $95K +$2K +2.15% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $374K $94K +$1K +1.08% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $373K $94K +$1K +1.08% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $372K $93K +$1K +1.09% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-27
Q1 2020 $371K $93K +$1K +1.09% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $370K $93K +$1K +1.09% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-22
Q3 2019 $369K $93K -$1K -1.06% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $370K $92K -$5K -5.16% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-14
Q1 2019 $375K $92K -$4K -4.17% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $379K $92K -$4K -4.17% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q3 2018 $383K $94K -$2K -2.08% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $385K $97K +$3K +3.19% Apr 1, 2018 Jun 30, 2018 10-K 2019-09-30
Q1 2018 $382K $96K +$1K +1.05% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $381K $96K +$4K +4.35% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-08
Q3 2017 $377K $96K +$5K +5.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $372K $94K -$1K -1.05% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-11
Q1 2017 $373K $95K -$10K -9.52% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $383K $92K -$15K -14% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q3 2016 $398K $91K -$6K -6.19% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $404K $95K -$2K -2.06% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-11
Q1 2016 $406K $105K +$5K +5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $401K $107K +$7K +7% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $394K $97K $0 0% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $394K $97K +$8K +8.99% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-11
Q1 2015 $386K $100K +$6K +6.38% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $380K $100K +$20K +25% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-08
Q3 2014 $360K $97K +$75K +341% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $285K $89K Apr 1, 2014 Jun 30, 2014 10-K 2016-09-13
Q1 2014 $94K +$94K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $80K +$80K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 $22K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-16
Q4 2012 $0 Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.